Vascular Diseases  >>  Thymoglobulin (anti-thymocyte globulin (rabbit))  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
NCT00709293: Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients

Withdrawn
N/A
0
US
Anti-Thymocyte Globulin, ATG, Normal Saline
University of California, Los Angeles, Genzyme, a Sanofi Company
Ischemia Reperfusion Injury, Heart Transplantation
05/09
 
NCT01499147: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

Completed
N/A
100
US
fludarabine/busulfan, Fludarabine:, Fludarabine Phosphate, Fludara, Busulfan:, Busulfex, Myleran, fludarabine/ melphalan, Fludarabine phosphate, Melphalan:, Alkeran, ATG, Thymoglobulin
University of Illinois at Chicago
Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Multiple Myeloma, Lymphocytic Leukemia, Myeloproliferative Disorder, Polycythemia Vera, Myelofibrosis, Aplastic Anemia
05/13
05/13

Download Options